CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas
CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas
Recruiting · NCT07022964 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, primary cutaneous T-cell non-Hodgkin lymphoma | Recruiting | Phase 1 / Phase 2 | 2026-09-11 | NCT07022964 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing GoBroad Hospital | 42 |
| Ruijin Hospital | 454 |
| Shanghai Liquan Hospital | 11 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing GoBroad Hospital | Beijing | China | 5 |
| Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine | Shanghai | China | 3 |
| Shanghai Liquan Hospital | Shanghai | China | 1 |